This inventor holds 1 USPTO granted patent. Top assignee: Welfide Corporation. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Nobuhiro Sakurai: Innovator in Prophylactic and Therapeutic Agents
Introduction
Nobuhiro Sakurai is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of medicine, particularly in the development of agents for the treatment of diseases caused by Helicobacter infections. His innovative work has the potential to improve patient outcomes and enhance therapeutic options.
Latest Patents
Nobuhiro Sakurai holds a patent for a prophylactic or therapeutic agent for diseases attributable to infection with Helicobacter. The patent describes an agent that comprises (S)-1-cyclopropyl-1,4-dihydro-7-[2-(N,N-dimethylaminomethyl)morpholino]-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof. This agent is effective even when used alone in small doses for short periods. It is almost free of problematic side effects such as tolerance and diarrhea, making it low toxic and capable of safe bacterial eradication. The invention is particularly useful for the prophylaxis and treatment of diseases such as gastritis, gastric ulcer, duodenal ulcer, malignant lymphoma, and gastric cancer.
Career Highlights
Nobuhiro Sakurai is associated with Welfide Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to treating Helicobacter-related diseases. With a focus on safety and efficacy, Sakurai's contributions are paving the way for new therapeutic options in the medical field.
Collaborations
Nobuhiro Sakurai has collaborated with notable colleagues, including Fumihiro Hirayama and Mitsuharu Sano. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their collective research efforts.
Conclusion
Nobuhiro Sakurai is a distinguished inventor whose work in developing therapeutic agents for Helicobacter infections is noteworthy. His innovative approach and dedication to improving patient care highlight the importance of research in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile